Knockdown of Peroxiredoxin VI in K562 Cells Stably Transfected with Oxidase Components Reduces NADPH Oxidase Activity in Response to PMA and fMLP.

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 2416-2416
Author(s):  
Daniel R. Ambruso ◽  
Gail Thurman

Abstract Introduction: An intact respiratory burst is critical to the microbicidal activity of neutrophils. The respiratory burst is initiated by assembly and activation of the NADPH oxidase complex. We recently identified a 29 kDa neutrophil protein which binds p67phox, is identified as peroxiredoxin VI by sequence and activity, translocates to the plasma membrane of neutrophils during activation and enhances superoxide anion (O2−) production in a cell-free assay exhibiting saturable kinetics. The activity of p29 peroxiredoxin (Prx) requires cysteine residues of the protein. The present studies demonstrate the requirement of p29 Prx for optimal oxidase activity in intact cells. Methods: K562 cells stably transfected with p47phox, p60phox, gp91phox and the low affinity fMLP receptor and expressing p22phox, p40phox and Rac were grown in tissue culture at 37°C in 5% CO2 with RPMI and 10% fetal calf serum. Three siRNA molecules (Q, A1, A2) as well as non-interfering RNA (Nsi) used as a control were obtained commercially. Transfection of K562 cells was completed with Nucleofector technology (Amaxa Biosystems, Gaithersburg, MD) using Solution L and protocol T020. Transfection was >90% by expression of a GFP plasmid; viability after the procedure was >90%. O2− was measured after stimulation with PMA (200 ng/ml) as SOD inhibitable cytochrome c reduction or in response to fMLP (1 μM) by the addition of Diogenes (National Diagnostics) and detection of chemiluminescence in a luminometer (FB12, Berthod Detection Systems, Pforzheim, Germany) as relative light units. Cell lysates were made with the addition of 10% Triton X-100 and stored at −70°C. Proteins (5–10μg of cell lysate) were separated on a 10% SDS-PAGE and blotted onto nitrocellulose. Detection of specific proteins was completed using polyclonal antibodies to p29 Prx and to other phox proteins and actin and secondary antibodies with a chemiluminescent technique. Results: Transfection of the K561 cells with Q, A1, and A2 resulted in a knockdown of p29 Prx (25–40%) compared to Nsi. Optimal knockdown occurred in the presence of 2μM siRNA, at 48 hours after transfection. No changes in actin, p67phox, p47phox, p40phox, p22phox or gp91phox were documented with nucleofection, siRNAs or Nsi. In 5 separate experiments, knockdown of p29 Prx resulted in a decrease (p<0.05) in O2− production (PMA) or O2− associated chemiluminescence (fMLP), see Figure (columns and bars represent mean ± SEM). Conclusion: O2− production in response to PMA or fMLP was reduced in K562 cells with a knockdown of p29. These results extend previous studies and demonstrate the requirement of p29 Prx, peroxiredoxin VI, for optimal NADPH oxidase activity within intact cells. Figure Figure

Blood ◽  
1992 ◽  
Vol 79 (6) ◽  
pp. 1558-1562 ◽  
Author(s):  
RC Woodman ◽  
RW Erickson ◽  
J Rae ◽  
HS Jaffe ◽  
JT Curnutte

Recombinant interferon-gamma (rIFN-gamma) therapy has become an effective form of prophylaxis for patients with chronic granulomatous disease (CGD). Preliminary studies with CGD suggested that rIFN-gamma treatment enhanced phagocyte oxidase activity and increased superoxide (O2-) production. We evaluated several aspects of neutrophil NADPH oxidase activity in 19 CGD patients (representing all four known types of CGD) receiving prolonged rIFN-gamma therapy (6 to 27 months). In contrast to earlier studies, we failed to detect any improvement in neutrophil NADPH oxidase activity in 18 of the 19 CGD patients as determined by (1) intact cell O2- production (continuous assay), (2) nitroblue tetrazolium (NBT) staining, (3) cytochrome b558 spectroscopy, and (4) activity levels of cytosol and membrane oxidase components using a cell-free activation system. One patient with a variant form of X-linked CGD had a transient increase in neutrophil O2- production following 3 months of rIFN-gamma therapy. However, this was not sustained, and was not associated with any change in cytochrome b levels. In some patients, rIFN-gamma therapy was associated with the appearance of a small subset of circulating monocytes (1% to 20%) that were NBT-positive. Although the functional significance of this monocyte subpopulation needs to be determined, these results suggest that one possible mechanism by which rIFN-gamma may benefit CGD patients is by partially correcting the respiratory burst defect in a subset of monocytes. We conclude that the clinical benefit of prolonged rIFN-gamma therapy in the vast majority of CGD patients is not due to enhanced neutrophil NADPH oxidase activity. The mechanism of action of rIFN-gamma in most CGD patients remains unknown.


Blood ◽  
1982 ◽  
Vol 60 (2) ◽  
pp. 333-339 ◽  
Author(s):  
AI Tauber ◽  
DB Brettler ◽  
EA Kennington ◽  
PM Blumberg

Abstract Phorbol esters are potent stimulants of the respiratory burst of the human neutrophil as assessed by superoxide (O2-) generation in whole cells and by NADPH-oxidase activity in a broken-cell 27,000-g particulate fraction. Phorbol 12-myristate, 13-acetate (PMA) and phorbol 12,13-dibutyrate (PDBu) stimulate production of O2- by human neutrophils with ED50 concentrations of 3.9 +/- 2.1 and 41.7 +/- 7.1 nM, respectively. The relation of biologic activity to receptor occupancy was assessed with binding studies of PMA and PDBu. Phorbol ester binding revealed a single high affinity phorbol ester receptor present at 7.6 x 10(5) sites/cell. The binding affinities for PMA and PDBu, 4.9 nM and 38.4 nM, respectively, agreed quantitatively with that of biologic potencies. Because of the high concentration of phorbol ester receptors (up to 125 nM) and the large amount of nonspecific binding at high cell density, apparent discrepancies between ED50′s for NADPH-oxidase and whole cell O2- generation were noted. With the use of low cell concentrations, quantitative agreement between intact cell production of O2-, NADPH-oxidase activity, and receptor binding was found. These results further support the identity of the NADPH-oxidase as the enzymatic source of respiratory burst O2- production in human neutrophils.


2010 ◽  
Vol 120 (8) ◽  
pp. 321-333 ◽  
Author(s):  
Rocío López-Sepúlveda ◽  
Manuel Gómez-Guzmán ◽  
Maria José Zarzuelo ◽  
Miguel Romero ◽  
Manuel Sánchez ◽  
...  

RWPs (red wine polyphenols) exert antihypertensive effects and improve endothelial function by reducing the plasma levels of ET-1 (endothelin-1) and the subsequent vascular production of O2•− (superoxide anion). Our present study was designed to evaluate whether RWPs act directly in the vascular wall improving endothelial dysfunction and O2•− production induced by ET-1 and to analyse the compounds responsible for these protective effects. We incubated rat isolated aortic rings in the presence or absence of ET-1 (10 nM) and RWPs (10−4 to 10−2 g/l) or catechin (0.2 μM), epicatechin (10 μM) and resveratrol (0.1 μM). ET-1 reduced the relaxant responses to acetylcholine, increased intracellular O2•− production, NADPH oxidase activity and protein expression of NADPH oxidase subunit p47phox. All these changes were prevented by RWPs. The preventive effects of RWPs were unaffected by co-incubation with either ICI-182780, an ER (oestrogen receptor) antagonist, or GW9662, a PPARγ (peroxisome-proliferator-activated receptor γ) antagonist. RWPs inhibited the phosphorylation of the mitogen-activated protein kinase, ERK1/2 (extracellular signal-regulated kinase 1/2), a key regulator of p47phox expression in response to ET-1. When the isolated polyphenols were tested, at the concentrations found in 10−2 g/l RWPs, only epicatechin prevented endothelial dysfunction and all biochemical changes induced by ET-1 in the vascular wall. Taken together, these results indicate that RWPs prevent ET-1-induced vascular O2•− production by reducing overexpression of p47phox and the subsequent increased NADPH oxidase activity, leading to improvement in endothelial function. The effects of RWPs appear to be independent of ER and PPARγ activation and are related to ERK1/2 inhibition.


1999 ◽  
Vol 276 (6) ◽  
pp. R1587-R1594 ◽  
Author(s):  
Christopher C. Nessel ◽  
William L. Henry ◽  
Balduino Mastrofrancesco ◽  
Jonathan S. Reichner ◽  
Jorge E. Albina

Macrophages from experimental wounds in rats were tested for their capacity to generate reactive oxygen intermediates. Measurements of superoxide and H2O2release, [Formula: see text]-dependent lucigenin chemiluminescence, oxygen consumption, hexose monophosphate shunt flux, and NADPH oxidase activity in cell lysates indicated, at best, the presence of a vestigial respiratory burst response in these cells. The inability of wound cells to release[Formula: see text] was not rekindled by priming with endotoxin or interferon-γ in vivo or in vitro. NADPH oxidase activity in a cell-free system demonstrated that wound macrophage membranes, but not their cytosols, were capable of sustaining maximal rates of [Formula: see text] production when mixed with their corresponding counterparts from human neutrophils. Immune detection experiments showed wound macrophages to be particularly deficient in the cytosolic component of the NADPH oxidase p47- phox. Addition of recombinant p47- phox to the human neutrophil-cell membrane/wound macrophage cytosol cell-free oxidase assay, however, failed to support[Formula: see text] production. Present findings indicate an unexpected deficit of wound macrophages in their capacity to generate reactive oxygen intermediates.


Blood ◽  
1982 ◽  
Vol 60 (2) ◽  
pp. 333-339
Author(s):  
AI Tauber ◽  
DB Brettler ◽  
EA Kennington ◽  
PM Blumberg

Phorbol esters are potent stimulants of the respiratory burst of the human neutrophil as assessed by superoxide (O2-) generation in whole cells and by NADPH-oxidase activity in a broken-cell 27,000-g particulate fraction. Phorbol 12-myristate, 13-acetate (PMA) and phorbol 12,13-dibutyrate (PDBu) stimulate production of O2- by human neutrophils with ED50 concentrations of 3.9 +/- 2.1 and 41.7 +/- 7.1 nM, respectively. The relation of biologic activity to receptor occupancy was assessed with binding studies of PMA and PDBu. Phorbol ester binding revealed a single high affinity phorbol ester receptor present at 7.6 x 10(5) sites/cell. The binding affinities for PMA and PDBu, 4.9 nM and 38.4 nM, respectively, agreed quantitatively with that of biologic potencies. Because of the high concentration of phorbol ester receptors (up to 125 nM) and the large amount of nonspecific binding at high cell density, apparent discrepancies between ED50′s for NADPH-oxidase and whole cell O2- generation were noted. With the use of low cell concentrations, quantitative agreement between intact cell production of O2-, NADPH-oxidase activity, and receptor binding was found. These results further support the identity of the NADPH-oxidase as the enzymatic source of respiratory burst O2- production in human neutrophils.


2001 ◽  
Vol 29 (3) ◽  
pp. 269-275 ◽  
Author(s):  
Herman Sahlin ◽  
Håkan Nygren

A method was developed for testing the cytotoxicity of various bandage-like wound dressings and gel wound dressings. In this method, the ability of human polymor-phonuclear neutrophils (PMNs) to initiate a respiratory burst after exposure to the various wound dressings is used as a marker of cytotoxicity. Luminol-amplified chemiluminescence stimulated with opsonised zymosan or phorbol 12-myristate 13-acetate (PMA) is used to measure the degree of activation of the respiratory burst, i.e. the NADPH oxidase activity, after exposure to wound dressings. Opsonised zymosan (material from yeast cell walls) is a phagocytic stimulus that activates the NADPH oxidase by binding to Fc-receptors and complement receptors, and functions as an artificial bacterium, whereas PMA activates the NADPH oxidase by direct activation of protein kinase C. NADPH oxidase activity was inhibited by several wound dressings. The down-regulation of the respiratory burst is detrimental to the bactericial effect of PMNs, and can be used as a marker for the cytotoxicity of wound-dressing materials.


Blood ◽  
1992 ◽  
Vol 79 (6) ◽  
pp. 1558-1562 ◽  
Author(s):  
RC Woodman ◽  
RW Erickson ◽  
J Rae ◽  
HS Jaffe ◽  
JT Curnutte

Abstract Recombinant interferon-gamma (rIFN-gamma) therapy has become an effective form of prophylaxis for patients with chronic granulomatous disease (CGD). Preliminary studies with CGD suggested that rIFN-gamma treatment enhanced phagocyte oxidase activity and increased superoxide (O2-) production. We evaluated several aspects of neutrophil NADPH oxidase activity in 19 CGD patients (representing all four known types of CGD) receiving prolonged rIFN-gamma therapy (6 to 27 months). In contrast to earlier studies, we failed to detect any improvement in neutrophil NADPH oxidase activity in 18 of the 19 CGD patients as determined by (1) intact cell O2- production (continuous assay), (2) nitroblue tetrazolium (NBT) staining, (3) cytochrome b558 spectroscopy, and (4) activity levels of cytosol and membrane oxidase components using a cell-free activation system. One patient with a variant form of X-linked CGD had a transient increase in neutrophil O2- production following 3 months of rIFN-gamma therapy. However, this was not sustained, and was not associated with any change in cytochrome b levels. In some patients, rIFN-gamma therapy was associated with the appearance of a small subset of circulating monocytes (1% to 20%) that were NBT-positive. Although the functional significance of this monocyte subpopulation needs to be determined, these results suggest that one possible mechanism by which rIFN-gamma may benefit CGD patients is by partially correcting the respiratory burst defect in a subset of monocytes. We conclude that the clinical benefit of prolonged rIFN-gamma therapy in the vast majority of CGD patients is not due to enhanced neutrophil NADPH oxidase activity. The mechanism of action of rIFN-gamma in most CGD patients remains unknown.


Sign in / Sign up

Export Citation Format

Share Document